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AIM AND OBJECTIVE:  
➢ To evaluate the salivary levels of chemerin in three groups i. systemically and 
periodontally healthy subjects ii. systemically healthy subjects with chronic 
periodontitis iii. Type II Diabetes Mellitus subjects with chronic periodontitis. 
➢ To compare the salivary levels of chemerin among systemically and periodontally 
healthy subjects, subjects with CP with / without Type II DM. 
➢ To correlate the salivary levels of chemerin with Glycated Hemoglobin (HbA1c) and 
Clinical Attachment level (CAL) in systemically and periodontally healthy subjects, 
subjects with chronic periodontitis with / without Type II DM. 
MATERIALS AND METHODS: 
 A total of 75 subjects were included in the study, who were divided into three groups: 
Group – I (Systemically & periodontally healthy n = 25); Group – II (Sytemically healthy 
with generalized chronic periodontitis n = 25); Group – III (Generalized chronic periodontitis 
with Type – II Diabetes Mellitus n = 25).  The clinical parameters including Plaque index 
(PI), Gingival index (GI), Probing depth (PD), Clinical attachment level (CAL) and Body 
mass index (BMI) and haematological parameters like Random blood glucose (RBG), 
Glycated haemoglobin (HbA1c) levels were recorded and saliva samples were collected from 
all the subjects prior to non-surgical periodontal therapy. The levels of chemerin in saliva 
samples were analysed by using a sandwich enzyme-linked immunosorbent assay (ELISA). 
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STATISTICAL ANALYSIS: 
 Data were analysed using the statistical package for the Social Sciences 
(SPSS, ver.18.0; SPSS Inc., Chicago, IL, USA). Shapiro Wilks test was used to assess 
normality of the obtained data. Data were found to be in non-normal distribution hence 
descriptive statistics were obtained. Comparison of variables between the study groups were 
performed using Kruskal Wallis H test. Kendall's tau correlation coefficient was employed to 
find correlation between overall volumes of chemerin with HbA1c levels and CAL. 
 
RESULTS: 
                The clinical parameters (PI, GI, PPD, CAL and BMI) were elevated in group-III 
and group-II and least in group-I and showed statistical significance (p < 0.05). 
Haematological parameters (RBG and HbA1c) showed statistical significant elevated values 
in group-III compared to group-II and group-I (p < 0.05). Higher salivary chemerin levels 
were observed in group-III (71.4742 ng/ml) compared to group-II (47.8733 ng/ml) and 
group-I (43.8068 ng/ml). The differences were not statistically significant (p < 0.172). There 
is no statistically significant correlation observed between chemerin and HbA1c (p - 0.077); 
chemerin and CAL (p - 0.115). 
 
SUMMARY AND CONCLUSION: 
 Chemerin in saliva can be considered as a biomarker for subjects with chronic 
periodontitis with / without Type-II DM but the difference was not statistically significant. 
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